ADHD in the News 2026-02-12
Psychologists underserve adults with ADHD
Q&A: Only a fourth of psychologists advertise providing ADHD care, far below the rates for other psychiatric conditions.
ADHD Identified as Causal Risk Factor for Coronary Artery Disease and Heart Failure
Key point: Genetically predicted ADHD was associated with higher BMI, increased odds of type 2 diabetes, and a greater likelihood of smoking initiation.
ADHD Symptoms Predict Distinct Creative Problem-Solving Styles and Superior Solving Ability
Individuals with strong attention-deficit/hyperactivity disorder (ADHD) symptoms, related to inefficient cognitive executive function, may experience a surprising benefit: a natural inclination toward a type of intuitive thinking that supports creative breakthroughs, according to a new study from Drexel University researchers.
My 11-year-old treats our house like a personal gymnasium. I’m at my wit’s end.
Letter writer is stuck in a frustrating cycle of constantly telling their son with ADHD to stop certain behaviors.
When ADHD is talked about as a fad – it does more than misrepresent science (Opinion)
Public conversations about disability are never neutral. When ADHD is framed as a social media trend, real people pay the price with delayed diagnoses and years of self-doubt
Neurodivergent youth in the U.S. are at increased risk for dating abuse, according to study
A study from Boston University has found that 74% of neurodivergent youth in the U.S. who have had a dating partner in the past year have experienced one or more forms of psychological, cyber, physical, or sexual dating abuse. These youth had twice the odds of experiencing dating abuse victimization in the past year than youth who were not neurodivergent.
Severe teen ADHD symptoms predict lower income and higher arrest rates by age 40
A longitudinal study in Christchurch, New Zealand found that individuals who displayed the most severe ADHD symptoms as adolescents were at an elevated risk of developing substance use disorder, depression, and suicidal ideation in early adulthood. They were also more likely to engage in crime and be unemployed. These individuals tended to have lower income and living standards, and less stable relationships. The paper was published in the British Journal of Psychiatry.
ADHD Women Face More Perimenopausal Symptoms
Key points: Women with ADHD experience more perimenopausal symptoms, and earlier in life. This link may be due to consequences of ADHD such as anxiety and lower socio economic status. More intense symptoms also come from the relationship between estrogen and ADHD. Interventions to reduce chronic stress could promise to alleviate some difficulties among women with ADHD.
Aldo Conti, PhD, says trigeminal nerve stimulation ineffective for pediatric ADHD
In a recent interview with Contemporary Pediatrics, Aldo A. Conti, PhD, MsC, BsC, CPsychol, research associate at King’s College London, discussed findings from a large, multicenter clinical trial evaluating the safety and efficacy of trigeminal nerve stimulation (TNS), a noninvasive brain stimulation device marketed for children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
Journal Digest: GLP-1s, Co-Occurring Borderline and ADHD, and More
Six in 10 Patients With Severe Borderline Personality Disorder Have Symptoms of ADHD
Attention-deficit/hyperactivity disorder (ADHD) may be a common comorbid condition in patients with severe borderline personality disorder, a study in Psychiatric Research & Clinical Practice has found.
Evening Chronotypes and Circadian Dysregulation Prevalent in Adult ADHD
Sleep disorders and poor sleep quality are widespread among adults with attention deficit-hyperactivity disorder (ADHD), with sleep dysregulation being pronounced in patients with ADHD and psychiatric comorbidities. These study findings were published in SN Comprehensive Clinical Medicine.
Otsuka awareness campaign urges HCPs to see ‘All of ADHD’
A new campaign from Otsuka aims to educate healthcare professionals about the far-reaching impacts of attention-deficit/hyperactivity disorder (ADHD) on patients’ lives, beyond just the diagnostic symptoms of the condition.
Lisdexamfetamine Dimesylate Oral Solution for ADHD to Be Available Mid-2026
Azurity Pharmaceuticals has announced that lisdexamfetamine dimesylate (Arynta) oral solution will be available mid-2026 for treating attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients aged 6 years and older.1 Arynta gained US Food and Drug Administration approval back on June 16, 2025, for the treatment of ADHD in adults and pediatric patients 6 years and older, and moderate to severe binge eating disorder in adults.2
Alton Towers U-turns on plan to restrict disability pass
Merlin Entertainments has backtracked on its controversial plan to tighten access to its disability queuing system at its theme parks following strong criticism from people with autism, ADHD and anxiety. The company had planned to introduce new eligibility rules for its Ride Access Pass (RAP), which provides a non-queueing option for people unable to stand in long lines.